AR and YAP crosstalk: impacts on therapeutic strategies in prostate cancer
Prostate cancer ranks as one of the most common types of cancer affecting men worldwide, and its progression is shaped by a diverse array of influencing factors. The AR signaling pathway plays a pivotal role in the pathogenesis of prostate cancer. While existing anti-androgen treatments show initial...
Saved in:
| Main Authors: | Guansong Zheng, Zhaojie Yan, Junrong Zou, Xiaofeng Zou, Keqiang Chai, Guoxi Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1520808/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cathepsin B in urological tumors: unraveling its role and therapeutic potential
by: Zhaojie Yan, et al.
Published: (2025-05-01) -
PPARα regulates YAP protein levels and activity by affecting its ubiquitination modification
by: Wenhong Zhou, et al.
Published: (2025-02-01) -
Coordinated AR and microRNA regulation in prostate cancer
by: Ieva Eringyte, et al.
Published: (2020-07-01) -
Precision targeting of androgen receptor–ferroptosis crosstalk in prostate cancer: From mechanisms to therapeutic strategies
by: Dongfang Lv, et al.
Published: (2025-09-01) -
Androgen receptor inhibitors in treating prostate cancer
by: Ryan N Cole, et al.
Published: (2025-03-01)